Deanna Bajala
Family Medicine · Saint Louis, MONPI 1689038077
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $502 and has fallen 91.5% since, to $43 in 2025.
Across 64 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$124
- Bayer$92
- Amgen$91
- GSK$90
- Novo Nordisk$87
- AstraZeneca$72
- plus $566 from 19 others
What the payments were for
- Food & beverage$1,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $124 |
| Bayer | 5 | $92 |
| Amgen | 6 | $91 |
| GSK | 4 | $90 |
| Novo Nordisk | 6 | $87 |
| AstraZeneca | 5 | $72 |
| Lilly USA, LLC | 4 | $66 |
| Novartis | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Boehringer Ingelheim | 3 | $54 |
| Medtronic | 2 | $42 |
| Viiv Healthcare Company | 2 | $33 |
| Neurelis, Inc. | 2 | $33 |
| Shield Therapeutics Inc | 1 | $24 |
| Eisai Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Exact Sciences | 1 | $18 |
| AbbVie | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,122 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 21 | $20,129 |
| EliquisApixaban | 11 | $13,661 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,634 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 63 | $6,175 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 11 | $3,315 |
| Entacapone | 12 | $3,032 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 103 | $2,479 |
| Diclofenac Sodium | 47 | $1,064 |
| Azelastine Hcl | 33 | $1,050 |
| Primidone | 17 | $938 |
| Fluticasone Propionate | 83 | $833 |
| Atorvastatin Calcium | 140 | $795 |
| Gabapentin | 89 | $695 |
| Losartan Potassium | 79 | $669 |
| Levothyroxine Sodium | 44 | $555 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $66 | $20,12921 claims |
| PfizerEliquis | $124 | $13,66111 claims |
| GSKTrelegy Ellipta, Arexvy | $90 | $12,94922 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $18122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.